| ²é¿´: 968 | »Ø¸´: 6 | |||
[½»Á÷]
ÎÄÏ×·ÖÏí | ÃâÒßµ÷¿ØÁªºÏÉñ¾µ÷¿Ø£¬IFÓÉ11.4Ìá¸ßΪ25.5
|
|||
|
ÃâÒßµ÷¿ØÊÇÖ¸»úÌå¶ÔÍâ½ç´Ì¼¤×ö³öµÄÃâÒß·´Ó¦¹ý³ÌÖУ¬Í¨¹ý¸÷ÖÖµ÷¿Ø»úÖÆÀ´±£³ÖÃâÒ߯½ºâ״̬£¬ÒÔ¼°»Ö¸´Õý³£ÃâÒßÓ¦´ðµÄÄÜÁ¦¡£ ½üÄêÀ´£¬ÃâÒßµ÷¿ØÏà¹ØµÄÑо¿²ã³ö²»Ç2023ÄêÖбêÊý¸ß´ï985¸ö£¬¿É¼û´ó¼Ò¶ÔÓÚÕâÒ»Ñо¿·½ÏòµÄÈÈÖÔ¡£½ñÌìСÖúÊÖ¸ø´ó¼ÒÕûÀíÁ˼¸Æª½üÄê·¢±íµÄ¸ß·ÖÎÄÕ£¬Óë´ó¼Ò¹²Í¬Ñ§Ï°Ò»ÏÂÃâÒßµ÷¿Ø·½ÏòÓÐÄÄЩеÄÑо¿Ë¼Â·¡£ 1¡¢Cell£¨IF=64.5£©£¬C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infection ϵͳÐÔÄîÖé¾ú¸ÐȾÊÇÒ»ÖÖ³£¼ûµÄ¡¢¸ßËÀÍöÂʵÄÒ½ÔºÕæ¾ú¸ÐȾ¡£³öºõÒâÁϵÄÊÇ£¬ËüÒѳÉΪ¿¹²¹ÌåC5°ÐÏòµ¥¿Ë¡¿¹ÌåÖÎÁƵIJ¢·¢Ö¢£¬±íÃ÷C5ÔÚ¿¹Õæ¾úÃâÒßÖоßÓÐÏà¹Ø×÷Óᣱ¾´ÎÑо¿È·¶¨ÁËÔÚÄîÖé¾úѪ֢»¼ÕßÖÐÓÕµ¼µÄ²¹Ìåϵͳ»ùÒòת¼ΪÊ×λµÄÉúÎï;¾¶£¬²¢Ô¤²âÆäÓëÄîÖé¾úѪ֢µÄÏà¹ØÐÔ¡£´Ó»úÖÆÉÏ¿´£¬C5a-C5aR1ͨ¹ý´Ì¼¤ÍÌÊÉϸ°ûЧӦ¹¦ÄÜÒÔ¼°ERKºÍAKTÒÀÀµµÄ¸ÐȾ×éÖ¯´æ»î£¬´Ù½øÐ¡ÊóÈ«ÉíÐÔÄîÖé¾ú²¡Ä£ÐÍÖеÄÕæ¾úÇå³ýºÍËÞÖ÷´æ»î¡£ÇóýC5ar1»ùÒòÖØ¹¹ÁËmTORÏÂÓεľÞÊÉϸ°û´úл£¬´Ù½øÁËËüÃǵĵòÍö£¬²¢Í¨¹ýÉöËðÉËÔö¼ÓÁËËÀÍöÂÊ¡£³ýÁ˸Îϸ°ûÀ´Ô´µÄ C5£¬ÓÉÍÌÊÉϸ°ûÄÚÔ´ÐÔ²úÉúµÄC5ÌṩÁË¿¹Õæ¾ú±£»¤µÄ¹Ø¼üµ×ÎѪÇåµÍC5aŨ¶È»ò¼õÉÙ°×ϸ°û C5±í´ïµÄC5¶à̬ÐÔÓ뻼ÕßÔ¤ºó²»Á¼Ïà¹Ø¡£×ÛÉÏËùÊö£¬¾Ö²¿ÍÌÊÉϸ°û²úÉúµÄC5²úÎïÊÚȨÁËÍÌÊÉϸ°ûµÄ¿¹Î¢ÉúÎ﹦ÄÜ£¬²¢ÔÚÈ«ÉíÕæ¾ú¸ÐȾ¹ý³ÌÖÐÌṩ¹ÌÓб£»¤¡£ 2¡¢Bioactive Materials£¨IF=18.9£©£¬A multifunctional neuromodulation platform utilizing Schwann cell-derived exosomes orchestrates bone microenvironment via immunomodulation, angiogenesis and osteogenesis ×î½üµÄÑо¿Ö¤Ã÷ÁËÔÚ¹ÇÔÙÉúÖÐÖØÏÖ¹Ç΢»·¾³ÖÐµÄ¶à·½ÃæÉúÎïѧÐèÇó¡£Éñ¾»¯¶ÔÓÚʵÏÖ¹Ç×éÖ¯¹¤³Ì£¨BTE£©ÖеĶàϵͳµ÷¿Ø¾ßÓо޴óDZÁ¦¡£È»¶ø£¬ËùÓÐÉæ¼°¹Ø¼ü¹ÇÐÞ¸´²½ÖèµÄÉñ¾²ßÂÔÉÐ䱨µÀ¡£ÔÚ±¾Ñо¿ÖУ¬Éñ¾×éÖ¯¹¤³ÌË®Äý½º·â×°µÄϸ°ûÀ´Ô´ÍâÃÚÌ壨SC Exo£©¡£ÕâÖÖ³ÖÐøÊÍ·ÅµÄ SC Exoϵͳͨ¹ý´Ù½øÌåÄÚµÄÉñ¾»¯¡¢ÃâÒßµ÷½Ú¡¢Ñª¹Ü»¯ºÍ³É¹Ç×÷ÓÃÏÔÖøÔöÇ¿Á˹ÇÔÙÉú¡£´ËÍ⣬ÌåÍâ½á¹û½øÒ»²½È·ÈÏÁ˸ÃϵͳÏÔÖøÓÕµ¼¾ÞÊÉϸ°ûµÄ M2¼«»¯¡¢HUVECsµÄ¹ÜÐγÉÒÔ¼° BMSCsµÄ³É¹Ç·Ö»¯¡£´ËÍ⣬ͨ¹ýÉϵ÷ TGF-¦Â1/SMAD2/3ÐźÅͨ·´Ù½øÁË BMSCsµÄ³É¹Ç¡£×ÛÉÏËùÊö£¬±¾Ñо¿ÖÐ×÷Õ߳ɹ¦¿ª·¢ÁËÒ»ÖÖеÄÎÞϸ°û¡¢Ò×ÓÚÖÆ±¸µÄ SC-ExoÉñ¾¹¤³Ì£¬Í¨¹ýе÷Õû¸ö¹ÇÓúºÏ΢»·¾³À´´Ù½ø¹ÇÔÙÉú£¬Õâ¿ÉÄÜΪ×éÖ¯¹¤³ÌºÍ¹ÇȱËðµÄÁÙ´²ÖÎÁÆÌṩһÖÖвßÂÔ¡£ 3¡¢Immunity£¨IF=32.4£©£¬Restraint of IFN-¦Ã expression through a distal silencer CNS-28 for tissue homeostasis IFN-¦ÃÊDz¸È鶯ÎïÓ¦¶Ô²¡¶¾»òϸ°ûÄÚϸ¾ú¸ÐȾµÄ¹Ø¼üϸ°ûÒò×Ó¡£ËäÈ»Ðí¶àÔöÇ¿×Ó±»ÃèÊöΪ´Ù½øIFN-¦Ã·´Ó¦£¬µ«»¹Ã»Óз¢ÏÖIfng»ùÒòµÄ³ÁĬÒò×Ó¡£Í¨¹ýÔÚIfng»ùÒòλµãÄÚµÄnaive CD4+Tϸ°ûÖмì²éH3K4me1×éµ°°×ÐÞÊΣ¬ÎÒÃǼø¶¨ÁËÒ»¸öÒÖÖÆÒò×Ó£¨CNS-28£©£¬¸ÃÒÖÖÆÒò×ÓÒÖÖÆIfng±í´ï¡£´Ó»úÖÆÉϽ²£¬CNS-28ͨ¹ýÒÔ GATA3ÒÀÀµT-betÒÀÀµµÄ·½Ê½¼õÉÙIfng»ùÒòλµãÄÚµÄÔöÇ¿×Ó-Æô¶¯×ÓÏ໥×÷ÓÃÀ´Î¬³ÖIfng³ÁĬ¡£ÔÚ¹¦ÄÜÉÏ£¬CNS-28ÔÚÏÈÌìÃâÒß·´Ó¦ºÍÊÊÓ¦ÐÔÃâÒß·´Ó¦ÆÚ¼äÒÖÖÆ NK ϸ°û¡¢CD4+ϸ°ûºÍ CD8+Tϸ°ûÖÐµÄ Ifngת¼¡£´ËÍ⣬ÓÉÓÚ IFN-¦Ã ±í´ïÉý¸ß£¬CNS-28 ȱ·¦µ¼ÖÂ2ÐÍ·´Ó¦±»ÒÖÖÆ£¬´Ó¶ø¸Ä±äÁËTh1ºÍTh2µÄģʽ¡£Òò´Ë£¬CNS-28»îÐÔͨ¹ýÓëIfng»ùÒòλµãÄ򵀮äËûµ÷¿ØË³Ê½Ôª¼þºÏ×÷£¬×î´óÏ޶ȵؼõÉÙ×ÔÉíÃâÒߣ¬´Ó¶øÈ·±£ÃâÒßϸ°û¾²Ö¹¡£ 4¡¢Nature Immunology£¨IF=30.5£©£¬Transcription factor EGR2 controls homing and pathogenicity of TH17 cells in the central nervous system TH17¼È±£»¤ÆÁÕÏ×éÖ¯ÓÖ´¥·¢×ÔÉíÃâÒß¡£ÕâЩ¶ÔÁ¢½ø³Ì±³ºóµÄ»úÖÆÉв»Çå³þ¡£±¾Ñо¿Öз¢ÏÖת¼Òò×ÓEGR2¿ØÖÆÖÐÊàÉñ¾ÏµÍ³£¨CNS£©ÖÐÖ²¡ÐÔTH17ϸ°ûµÄת¼³ÌÐò£¬µ«²»¿ØÖÆÆÁÕÏλµãµÄ±£»¤ÐÔTH17µÄת¼³ÌÐò¡£¶à·¢ÐÔÓ²»¯Ö¢»¼ÕߺÍ×ÔÉíÃâÒßÐÔÉñ¾Ñ×֢СÊóµÄËèÇÊ·´Ó¦ÐÔCD4+Tϸ°ûÖÐ EGR2ÏÔÖøÉý¸ß¡£EGR2ת¼³ÌÐò¾²Ä¬±àÖ¯ÔÚTH17ϸ°ûת¼µ÷¿ØÍøÂçÖУ¬²¢ÓëºËÐÄTH17ϸ°ûÌØÒìÐÔת¼Òò×ÓÖ®¼ä¾ßÓеĸ߶Ȼ¥ÁªÐÔ¡£´Ó»úÖÆÉϽ²£¬EGR2ͨ¹ýÉϵ÷Ó벡ÀýÏà¹Ø»ùÒòºÍËèÑùµ¥ºËϸ°ûÇ÷»¯Òò×Ó£¬ÔöÇ¿ TH17ϸ°û·Ö»¯ºÍËèÑùϸ°ûÏòCNSµÄ=¡£Egr2µÄTϸ°ûÌØÒìÐÔÇóýÔÚ²»Ëðº¦ËÞÖ÷¿ØÖƸÐȾÄÜÁ¦µÄÇé¿öϼõÇáÁËÉñ¾Ñ×Ö¢¡£×ÛÉÏËùÊö£¬EGR2ÔÚCNSµÄ²¡ÔÐÔTH17ϸ°ûÖе÷¿Ø×éÖ¯ÌØÒìºÍ¼²²¡ÌØÒ칦ÄÜ¡£ |
» ²ÂÄãϲ»¶
ÊÇ·ñÊôÓÚÆ¢ÉöÑôÐéÖ¤
ÒѾÓÐ0È˻ظ´
ÄÔ¹£ÔõôÖÎÁÆ
ÒѾÓÐ3È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ88È˻ظ´
ÄÔ¹£ÔõôÖÎÁÆ
ÒѾÓÐ0È˻ظ´
ÉúÎï×éÖ¯ÖÐÓÐÄ¿±ê·ÖÎöÎרÊôÐÔÔõô×ö
ÒѾÓÐ0È˻ظ´
¹ãÎ÷Ò½¿Æ´óѧ»ù´¡Ò½Ñ§Ôº×ÔÉíÃâÒß²¡¿ÎÌâ×éÕÐÊÕ»ù´¡Ò½Ñ§Ïà¹Ø×¨ÒµµÄµ÷¼ÁÑо¿Éú
ÒѾÓÐ2È˻ظ´
¹ãÎ÷Ò½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÕÐÊÕ»ù´¡Ò½Ñ§¡¢Ò©Ñ§¡¢ÉúÎï¼ìÑéÏà¹Ø×¨ÒµµÄÑо¿Éú
ÒѾÓÐ1È˻ظ´
Ò©Îï¼ì²âÖÐ΢ÉúÎïÏ޶ȼÆÊý½á¹ûÅжÏ
ÒѾÓÐ0È˻ظ´
É격×Ô¼ö
ÒѾÓÐ2È˻ظ´
Çë½Ìִҵҩʦ±¨¿¼µÄһЩÎÊÌâ
ÒѾÓÐ4È˻ظ´
Õâ¸ö×Ô·¢¼ÓÑõ·´Ó¦µÄ»úÀíÊÇʲô£¿
ÒѾÓÐ7È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
2027ÄêÉúÎïҽѧ¡¢Å©ÒµÓë¿É³ÖÐø·¢Õ¹¹ú¼Ê»áÒ飨BASD 2027£©
+1/909
2027Äê¼ÆËã»úÊÓ¾õ¡¢Éè¼ÆÓë·ÇÒÅÎÄ»¯´«²¥¹ú¼Ê»áÒ飨CVDC 2027£©
+1/875
´óÁ¬Àí¹¤´óѧ´óÁ¬Êи´ÔÓ¹¤Òµ³¡¾°¾ßÉíÖÇÄÜÖØµãʵÑéÊÒ¿ÆÑÐÖúÀíÕÐÆ¸ÆôÊÂ
+2/164
´óÁ¬Àí¹¤´óѧ¿ØÖÆ¿ÆÑ§Ó빤³ÌѧԺŷÓÂÊ¢½ÌÊÚ¿ÎÌâ×é2026Äê¿ÆÑÐÖúÀíÕÐÆ¸ÆôÊÂ
+2/164
°ÄÃÅ´óѧËïÅôÕ¹²©Ê¿¿ÎÌâ×éÕÐÊÕÈ«½±²©Ê¿Ñо¿Éú1Ãû
+2/94
º«¹úÈ«±±¹úÁ¢´óѧÇݲ¡Ñо¿Ëù²©Ê¿Ñо¿ÉúÕÐÉú¼òÕÂ
+2/60
ÇóÖúÐÏÆäÒãµÚËİæ»ù´¡Óлú»¯Ñ§PDF°æ
+1/32
¹ú¼Ò¼¶´óÈ˲ÅÍŶӣ¬»¶Ó˶²©Á¬¶ÁÍÆÃâÉú2Ãû£¡»¯Ñ§¡¢²ÄÁÏ¡¢Ê¯Ó͹¤³Ì£ºÓÍÌﻯѧ
+1/30
¼ÓÄôóUBC²©Ê¿ºóÕÐÆ¸£üÈ˹¤ÖÇÄÜ ¡Á µç³Ø
+1/18
¼ÓÄôóUBC²©Ê¿/²©Ê¿ºóÕÐÆ¸£üÈ˹¤ÖÇÄÜ ¡Á µç³Ø
+1/16
¡¾ÍÆÃâÕÐÉú¡¿ÕÐÊÕ²ÄÁÏ¡¢»¯¹¤¡¢»·¾³¡¢Ò±½ðÀàÍÆÃâÉú
+1/9
¼ÓÄôóUBC²©Ê¿ºóÕÐÆ¸£üÈ˹¤ÖÇÄÜ ¡Á µç³Ø
+1/9
½ñÌ찮˼Ψ¶ûµÄ¹ÙÍøÊDz»ÊDZ»ºÚ¿Í¹¥»÷ÁË
+1/5
¾ÞÊÉϸ°û¿Õ¼ä Marker ¼°Ôλ¼ì²â¼¼ÊõµÄÑо¿Ó¦ÓÃ
+1/5
°Ä´óÀûÑÇ ARC DECRA/Future FellowÍŶÓÕÐÊÕÁ¦Ñ§¡¢»úе¡¢ÍÁľµÈ·½ÏòÏîĿȫ½±²©Ê¿Éú
+1/2
»¶ÓÍÆ¼öºÍ×Ô¼öË¶Ê¿ÍÆÃâÉúºÍ˶²©Á¬¶ÁÍÆÃâÉú£¡ÖйúÁÖÒµ¿ÆÑ§Ñо¿Ôº²Ýѧ¡¢Éú̬ѧ·½Ïò¡£
+1/2
ÐÂÒ©Ñз¢ÎªÊ²Ã´ÕâôÄÑ£¿¶àÒò×Ó¼ì²âÈçºÎ³ÉΪ´´ÐÂÒ©µÄ"Êý¾ÝÒýÇæ"
+1/1
ԺʿÁìÏΣ¬ICBMBAÉúÎ﹦ÄܲÄÁÏÓëÉúÎïҽѧӦÓûáÒé³ÏÑûѧÕß¼ÓÈ룡
+1/1
»·¾³¿ØÖÆÓëÁ¼ÂÊÇ¿°ó¶¨£ºÊÖÌ×ÏäµÄ¹¤³Ì»¯½ø½×·¾¶
+1/1
·ÎÅݹàÏ´Òº¶àÒò×Ó¼ì²â¼¼Êõ¼°Ñù±¾¹æ·¶»¯´¦Àí²ßÂÔ
+1/1
6Â¥2024-08-06 16:40:20
¼òµ¥»Ø¸´
tzynew2Â¥
2024-08-06 08:47
»Ø¸´
ÉúÎïҽҩʵÑéÍâ°(½ð±Ò+1): лл²ÎÓë
i ·¢×ÔСľ³æAndroid¿Í»§¶Ë
zusn3Â¥
2024-08-06 10:50
»Ø¸´
nono20094Â¥
2024-08-06 11:57
»Ø¸´
ÉúÎïҽҩʵÑéÍâ°(½ð±Ò+1): лл²ÎÓë
¡¤
tfang5Â¥
2024-08-06 16:00
»Ø¸´
ÉúÎïҽҩʵÑéÍâ°(½ð±Ò+1): лл²ÎÓë
¸ý³½ÐÁ³ó7Â¥
2024-08-06 17:13
»Ø¸´










»Ø¸´´ËÂ¥